| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 620 |
| 1 | SILDENAFIL CITRATE | 463 |
| 2 | MACITENTAN | 453 |
| 3 | TREPROSTINIL | 408 |
| 4 | BOSENTAN | 347 |
| 5 | SILDENAFIL | 318 |
| 6 | TADALAFIL | 309 |
| 7 | EPOPROSTENOL | 252 |
| 8 | NINTEDANIB | 237 |
| 9 | SILDENAFIL POWDER, | 218 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 252 | 0.0192 |
| 1 | COLISTIMETHATE SODIUM | 14 | 0.0086 |
| 2 | ILOPROST | 8 | 0.0086 |
| 3 | LUMACAFTOR AND IVACAFTOR | 63 | 0.0074 |
| 4 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 5 | 0.0074 |
| 5 | NINTEDANIB | 237 | 0.0073 |
| 6 | BOSENTAN | 347 | 0.0069 |
| 7 | MACITENTAN | 453 | 0.0065 |
| 8 | AZTREONAM | 44 | 0.0061 |
| 9 | SILDENAFIL POWDER, | 218 | 0.0061 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 1061 |
| 1 | Prostacycline Vasodilator [EPC] | 623 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 515 |
| 3 | Corticosteroid [EPC] | 255 |
| 4 | Loop Diuretic [EPC] | 191 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 148 |
| 6 | Aminoglycoside Antibacterial [EPC] | 133 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 118 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 114 |
| 9 | Osmotic Laxative [EPC] | 114 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 8 | 0.0086 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 107 | 0.0062 |
| 2 | Recombinant Human Deoxyribonuclease 1 [EPC] | 118 | 0.0060 |
| 3 | Endothelin Receptor Antagonist [EPC] | 1061 | 0.0053 |
| 4 | Prostacycline Vasodilator [EPC] | 623 | 0.0045 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 148 | 0.0044 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 100 | 0.0038 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 515 | 0.0038 |
| 8 | Aminoglycoside Antibacterial [EPC] | 133 | 0.0030 |
| 9 | Interferon gamma [EPC] | 4 | 0.0028 |